Beijing Shijitan Hospital
Beijing, Beijing Municipality, 100038, China
NCT Number: NCT02154919
To compare the different effect of conservative pharmacotherapy and Staged Percutaneous Coronary Intervention (SPCI) on significant non-culprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) at presentation remains controversial
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Beijing, Beijing Municipality, 100038, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 360days
Beijing Shijitan Hospital, Capital Medical University
Other
Conservative Pharmacotherapy Versus Staged Percutaneous Coronary Intervention on Non-culprit Vessels for ST-Segment Elevation Myocardial Infarction Patients With Multivessel Disease
Acronym: CPVsSPCI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02445885
Cardiovascular Diseases, Heart Diseases
Copenhagen, Capital Region, Denmark
View Trial DetailsNCT05895123
Cardiovascular Diseases, Heart Diseases
Damanhūr, Egypt
View Trial DetailsNCT02641262
Cardiovascular Diseases, Heart Diseases
Zhengzhou, Henan, China
View Trial DetailsNCT03671603
Arterial Occlusive Diseases, Arteriosclerosis
Kaifeng, Contact:, China
View Trial Details